The Strategic Importance of DSUR Drafting and Submission

The DSUR Drafting and Submission process is the cornerstone of safety reporting during the clinical trial phase. An annual Developmental Safety Update Report (DSUR) ensures that regulators are kept informed of the evolving risk-benefit profile of an investigational drug.

Drafting for Regulatory Approval

Successful DSUR Drafting and Submission requires a meticulous review of all safety data collected during the reporting period. This includes data from both interventional and non-interventional studies.

For clinical trials aiming for Regulatory approvals, the DSUR must be synchronized with your Global Pharmacovigilance Strategy.